Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an increasingly r
ecognized cause of ventricular tachycardia and sudden cardiac death in youn
g people, notably young athletes. The best treatment is not clear, although
options include antiarrhythmic drugs, radiofrequency ablation, and implant
able defibrillators.